The Valley Desk

NCT02052739 · Interventional trial

Study to Evaluate SAGE-547 Injection as Adjunctive Therapy for the Treatment of Super-Refractory Status Epilepticus

Overall registry status Completed

Phase 1 · Phase 2

Conditions Super-refractory Status Epilepticus

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov